Federated Hermes’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-110
Closed -$1K 2324
2022
Q1
$1K Hold
110
﹤0.01% 2144
2021
Q4
$1K Hold
110
﹤0.01% 2182
2021
Q3
$2K Hold
110
﹤0.01% 2113
2021
Q2
$2K Buy
110
+10
+10% +$201 ﹤0.01% 2107
2021
Q1
$2K Buy
100
+56
+127% +$4.2K ﹤0.01% 2142
2020
Q4
$3K Buy
44
+13
+42% +$746 ﹤0.01% 2108
2020
Q3
$1K Buy
+31
New +$1.1K ﹤0.01% 2214
2020
Q1
Sell
-6
Closed -$1K 2387
2019
Q4
$1K Sell
6
-12
-67% -$446 ﹤0.01% 2166
2019
Q3
$1K Sell
18
-151
-89% -$6.63K ﹤0.01% 2152
2019
Q2
$8K Hold
169
﹤0.01% 1929
2019
Q1
$7K Buy
169
+103
+156% +$4.98K ﹤0.01% 1929
2018
Q4
$3K Buy
+66
New +$7.59K ﹤0.01% 2061
2017
Q2
Sell
-21
Closed -$7K 2203
2017
Q1
$7K Hold
21
﹤0.01% 1881
2016
Q4
$4K Buy
21
+4
+24% +$954 ﹤0.01% 1972
2016
Q3
$6K Buy
+17
New +$4.5K ﹤0.01% 1907

Other funds holding ACGN

Federated Hermes's ACGN Position: Q2 2022 in Review

Federated Hermes sold out of Aceragen Inc (ACGN) in Q2 2022, closing a stake of 110 shares — an estimated $1K sold.

Federated Hermes first reported a position in ACGN in Q3 2016 and held it in 15 quarters. The position peaked at $8K in Q2 2019. 33 funds tracked by Wall St. Rank hold ACGN as of Q2 2022.

  • Federated Hermes reported no remaining Aceragen Inc position as of Q2 2022 after selling out during the quarter.
  • Federated Hermes sold 110 Aceragen Inc shares in Q2 2022, an estimated $1K.
  • Federated Hermes first reported a position in Aceragen Inc in Q3 2016 and held it in 15 quarters.
  • Federated Hermes's Aceragen Inc position peaked at $8K in Q2 2019.
  • 33 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2022.

Based on Federated Hermes's 13F filing for Q2 2022, filed 15 Aug 2022.